Fever as a risk factor causing delayed elimination of methotrexate in pediatric patients receiving high doses of cancer chemotherapy

Author: Kagawa Yoshiyuki   Mukohara Rika   Hori Hiroki   Kawasaki Hajime   Komada Yoshihiro   Kojima Michio  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.54, Iss.1, 2004-07, pp. : 34-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content